Predictive Oncology Inc is a healthcare technology company focused on advancing personalized medicine through the use of artificial intelligence and machine learning
The company leverages a proprietary platform to analyze and model cancer treatment responses, aiming to provide insights that optimize therapeutic strategies for individual patients. By integrating extensive genomic and clinical data, Predictive Oncology seeks to improve patient outcomes and reduce the time and costs associated with drug development, ultimately enhancing the effectiveness of cancer therapies. Their innovative approach positions them at the forefront of cancer research, contributing to the development of more effective and tailored treatment options.
Predictive Oncology stock is trading higher on Tuesday after the company reported positive results from utilizing artificial intelligence for drug repurposing.
Predictive Oncology shares are blasting higher Thursday after the company announced it is expanding its AI and machine learning driven drug discovery platform to pursue discovery of novel biomarkers. Here's a look at what's going on:
Predictive Oncology shares are trading higher by 46.6% during Tuesday's session. The company announced positive results from a retrospective study conducted with UPMC Magee-Womens Hospital.
